BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10433373)

  • 1. In vitro screening of food peptides toxic for coeliac and other gluten-sensitive patients: a review.
    Silano M; De Vincenzi M
    Toxicology; 1999 Feb; 132(2-3):99-110. PubMed ID: 10433373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coeliac Disease: background and biochemical aspects.
    Hamer RJ
    Biotechnol Adv; 2005 Sep; 23(6):401-8. PubMed ID: 16006084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The precipitating factor in coeliac disease.
    Wieser H
    Baillieres Clin Gastroenterol; 1995 Jun; 9(2):191-207. PubMed ID: 7549024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.
    Vader LW; Stepniak DT; Bunnik EM; Kooy YM; de Haan W; Drijfhout JW; Van Veelen PA; Koning F
    Gastroenterology; 2003 Oct; 125(4):1105-13. PubMed ID: 14517794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
    Cornell HJ; Maxwell RJ
    Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wheat starch, gliadin, and the gluten-free diet.
    Thompson T
    J Am Diet Assoc; 2001 Dec; 101(12):1456-9. PubMed ID: 11762742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry, coeliac-toxicity and detection of gluten and related prolamins in foods.
    Skerritt JH; Devery JM; Hill AS
    Panminerva Med; 1991; 33(2):65-74. PubMed ID: 1923557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution in research in prolamin toxicity: from bread to peptide.
    Hekkens WT
    Bibl Nutr Dieta; 1991; (48):90-104. PubMed ID: 1930127
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small peptide from durum wheat gliadin prevents cell agglutination induced by prolamin-peptides toxic in coeliac disease.
    De Vincenzi M; Gasbarrini G; Silano V
    Toxicology; 1997 Jul; 120(3):207-13. PubMed ID: 9217307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of gluten using a monoclonal antibody to a sequenced peptide of alpha-gliadin from the coeliac-activating domain I.
    Ellis HJ; Doyle AP; Wieser H; Sturgess RP; Day P; Ciclitira PJ
    J Biochem Biophys Methods; 1994 Jan; 28(1):77-82. PubMed ID: 7512105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A-gliadin.
    Ellis HJ; Rosen-Bronson S; O'Reilly N; Ciclitira PJ
    Gut; 1998 Aug; 43(2):190-5. PubMed ID: 10189843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coeliac disease: digestive, immunologic, and nutritional implications.
    Hekkens WT
    Bibl Nutr Dieta; 1992; (50):58-71. PubMed ID: 1288486
    [No Abstract]   [Full Text] [Related]  

  • 15. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.
    Ellis HJ; Doyle AP; Sturgess RP; Ciclitira PJ
    Gut; 1992 Nov; 33(11):1504-7. PubMed ID: 1280610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of the 'lectin hypothesis' in the aetiopathogenesis of coeliac disease.
    Colyer J; Farthing MJ; Kumar PJ; Clark ML; Ohannesian AD; Waldron NM
    Clin Sci (Lond); 1986 Jul; 71(1):105-10. PubMed ID: 3709069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of cereals that react with serum antibodies in patients with coeliac disease.
    Troncone R; Auricchio S; De Vincenzi M; Donatiello A; Farris E; Silano V
    J Pediatr Gastroenterol Nutr; 1987; 6(3):346-50. PubMed ID: 3430243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Celiac disease (gluten sensitive enteropathy)].
    Granditsch G
    Padiatr Padol; 1990; 25(2):67-84. PubMed ID: 2192342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive antinutritional peptides derived from cereal prolamins: a review.
    Silano M; De Vincenzi M
    Nahrung; 1999 Jun; 43(3):175-84. PubMed ID: 10399351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferative response of the lymphocytes of children with intolerance to gluten and to gliadin fractions and subfractions].
    Mougenot JF; Jos J; Charbonnier L; Mosse J; Polonovski C
    Ann Med Interne (Paris); 1978 Feb; 129(2):141-2. PubMed ID: 637471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.